Conformations of the monomeric hepatitis C virus RNA-dependent RNA polymerase

Virus Adaptation and Treatment

Volumn 2, Issue 1, 2010, Pages 21-39

  Chinnaswamy, Sreedhar ^a,b   Murali, Ayaluru ^a   Cai, Hui ^a   Yi, Guanghui ^a   Palaninathan, Satheesh ^b   Kao, C Cheng ^a  

^a INDIANA UNIVERSITY   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Conformational change; Hepatitis C virus; RNA dependent RNA polymerase; Single particle reconstruction

Indexed keywords

AMINO ACID; MONOMER; RETINOBLASTOMA PROTEIN; RNA DIRECTED RNA POLYMERASE;

ARTICLE; BIOINFORMATICS; CONFORMATIONAL TRANSITION; CRYSTAL STRUCTURE; ELECTRON MICROSCOPY; ENZYME CONFORMATION; HEPATITIS C VIRUS; HUMAN; NONHUMAN; OLIGOMERIZATION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; RNA SYNTHESIS; VIRUS STRAIN; X RAY CRYSTALLOGRAPHY;

EID: 77953452896     PISSN: None     EISSN: 11791624     Source Type: Book Series    
DOI: None     Document Type: Article

References (45)

1. Wasley A, Alter MJ. Epidemiology of hepatitis C: Geographic differences and temporal trends. Semin Liver Dis. 2000;20:1-16.
2. Gomez L, Martell M, Quer J, et al. Hepatitis C viral quasispecies. J Viral Hepat. 1999;6:3-16.
3. Feld JJ, Hoofnagle JH. Mechanism of action of interferon and ribavirin in treatment of hepatitis C. Nature. 2005;436:967-972.
4. Burton JR Jr, Everson GT. HCV NS5B polymerase inhibitors. Clin Liver Dis. 2009;13:453-465.
5. Kao CC, Singh P, Ecker DJ. De novo initiation of viral RNA-dependent RNA synthesis. Virology. 2001;287:251-260.
6. Van Dijk AA, Makeyev EV, Bamford DH. Initiation of viral RNA-dependent RNA polymerization. J Gen Virol. 2004;85:1077-1093.
7. Kao C, Sun JH. Initiation of minus-strand RNA synthesis by the brome mosaic virus RNA-dependent RNA polymerase: Use of oligoribonucleotide primers. J Virol. 1996;70:6826-6830.
8. Simister P, Schmitt M, Geitmann M, et al. Structural and functional analysis of hepatitis C virus strain JFH1 polymerase. J Virol. 2009;83:11926-11939.
9. Bressanelli S, Tomei L, Roussel A, et al. Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus. Proc Natl Acad Sci U S A.1999;96:13034-13039.
10. Lesburg CA, Cable MB, Ferrari E, et al. Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site. Nat Struct Biol. 1999;6:937-943.
11. De Haseth PL, Zupancic M, Record MT. RNA polymerase-promoter interactions: The comings and goings of RNA polymerase. J Bacteriol. 1998;180:3019-3025.
12. Butcher SJ, Grimes JM, Makeyev EV, et al. A mechanism for initiating RNA-dependent RNA polymerization. Nature. 2001;410:235-240.
13. Chinnaswamy S, Yarbrough I, Palaninathan S, et al. A locking mechanism regulates RNA synthesis and host protein interaction by the hepatitis C virus polymerase. J Biol Chem. 2008;283:20535-20546.
14. Biswal BK, Cherney MM, Wang M, et al. Crystal structures of the RNA-dependent RNA polymerase genotype 2a of hepatitis C virus reveal two conformations and suggest mechanisms of inhibition by non-nucleoside inhibitors. J Biol Chem. 2005;280:18202-18210.
15. Munakata T, Nakamura M, Liang Y, et al. Down-regulation of the retinoblastoma tumor suppressor by the hepatitis C virus NS5B RNA-dependent RNA polymerase. Proc Natl Acad Sci U S A. 2005;102: 18159-18164.
16. Liu Z, Robida JM, Chinnaswamy S, et al. Mutations in the hepatitis C virus polymerase that increase RNA binding can confer resistance to cyclosporine A. Hepatology. 2009;50:25-33.
17. Ranjith-Kumar CT, Kim YC, Gutshall L, et al. Mechanism of de novo initiation by the hepatitis C virus RNA-dependent RNA polymerase: Role of divalent metals. J Virol. 2002;76:12513-12525.
18. Ludtke SJ, Jakana J, Song JL, et al. A 11.5 A single particle reconstruction of GroEL using EMAN. J Mol Biol. 2001;314:253-262.
19. Sun J, Duffy KE, Ranjith-Kumar CT, et al. Structural and functional analyses of the human Toll-like receptor 3. Role of glycosylation. J Biol Chem. 2006;281:11144-11151.
20. Pettersen EF, Goddard TD, Huang CC, et al. UCSF Chimera - a visualization system for exploratory research and analysis. J Comput Chem. 2004;25:1605-1612.
21. Los Alamos National Laboratory. Hepatitis C virus (HCV) Database Project. 2009. Available from: http://hcv.lanl.gov/. Accessed on February 20, 2010.
22. Cramer J, Jaeger J, Restle T. Biochemical and pre-steady-state kinetic characterization of the hepatitis C virus RNA polymerase (NS5B delta21, HC-J4). Biochemistry. 2006;45:3610-3619.
23. Pathak HB, Ghosh SK, Roberts AW, et al. Structure-function relationships of the RNA-dependent RNA polymerase from poliovirus (3Dpol). A surface of the primary oligomerization domain functions in capsid precursor processing and VPg uridylylation. J Biol Chem. 2002;277:31551-31562.
24. Lyle JM, Bullitt E, Bienz K, et al. Visualization and functional analysis of RNA-dependent RNA polymerase lattices. Science. 2002;296:2218-222.
25. Pata JD, Schultz SC, Kirkegaard K. Functional oligomerization of poliovirus RNA-dependent RNA polymerase. RNA. 1995;1:466-477.
26. Hobson SD, Rosenblum ES, Richards O, et al. Oligomeric structures of poliovirus polymerase are important for function. EMBO J. 2001;20:1153-1163.
27. Högbom M, Jäger K, Robel I, et al. The active form of the norovirus RNA-dependent RNA polymerase is a homodimer with cooperative activity. J Gen Virol. 2009;90:281-291.
28. Qin W, Luo H, Nomura T, et al. Oligomeric interaction of hepatitis C virus NS5B is critical for catalytic activity of RNA-dependent RNA polymerase. J Biol Chem. 2002;277:2132-2137.
29. Wang QM, Hockman MA, Staschke K, et al. Oligomerization and cooperative RNA synthesis activity of hepatitis C virus RNA-dependent RNA polymerase. J Virol. 2002;76:3865-3872.
30. Gu B, Gutshall LL, Maley D, et al. Mapping cooperative activity of the hepatitis C virus RNA-dependent RNA polymerase using genotype 1a-1b chimeras. Biochem Biophys Res Commun. 2004;313: 343-350.
31. Niesen FH, Berglund H, Vedadi M. The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability. Nat Protoc. 2007;2:2212-2221.
32. Yi G, Vaughan R, Yarbrough L, et al. RNA binding by the brome mosaic virus capsid protein and the regulation of viral RNA accumulation. J Mol Biol. 2009;391:314-326.
33. Kim MJ, Kao CC. Factors regulating template switch in vitro by viral RNA-dependent RNA polymerases: Implications for RNA-RNA recombination. Proc Natl Acad Sci U S A. 2001;98:4972-4977.
34. Murali A, Li X, Ranjith-Kumar CT, et al. Structure and function of LGP2, a DEX(D/H) helicase that regulates the innate immunity response. J Biol Chem. 2008;283:15825-15833.
35. Ranjith-Kumar CT, Ayaluru M, Dong W, et al. Agonist and antagonist recognition by RIG-I, a cytoplasmic innate immunity receptor. J Biol Chem. 2009;284:1155-1165.
36. Tina KG, Bhadra R, Srinivasan N. PIC: Protein Interactions Calculator. Nucleic Acids Res. 2007;35:W473-W476.
37. Takeuchi O, Akira S. Innate immunity to virus infection. Immunol Rev. 2009;227:75-86.
38. Kukolj G, McGibbon GA, McKercher G, et al. Binding site characterization and resistance to a class of non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase. J Biol Chem. 2005;280: 39260-39267.
39. Di Marco S, Volpari C, Tomei L, et al. Interdomain communication in hepatitis C virus polymerase abolished by small molecule inhibitors bound to a novel allosteric site. J Biol Chem. 2005;280: 29765-29770.
40. Tomei L, Altamura S, Bartholomew L, et al. Characterization of the inhibition of hepatitis C virus RNA replication by non-nucleosides. J Virol. 2004;78:938-946.
41. Love RA, Parge HE, Yu X, et al. Crystallographic identification of a noncompetitive inhibitor binding site on the hepatitis C virus NS5B RNA polymerase enzyme. J Virol. 2003;77:7575-7581.
42. Biswal BK, Wang M, Cherney MM, et al. Non-nucleoside inhibitors binding to hepatitis C virus NS5B polymerase reveal a novel mechanism of inhibition. J Mol Biol. 2006;361:33-45.
43. Dhanak D, Duffy K, Johnston VK, et al. Identification and biological characterization of heterocyclic inhibitors of the hepatitis C virus RNA-dependent RNA polymerase. J Biol Chem. 2002;277: 38322-38327.
44. Gu B, Johnston VK, Gutshall L, et al. Arresting initiation of hepatitis C virus RNA synthesis using heterocyclic derivatives. J Biol Chem. 2003;278:16602-16607.
45. Nyanguile O, Pauwels F, Van den Broeck W, et al. 1,5-Benzodiazepines, a novel class of hepatitis C virus polymerase nonnucleoside inhibitors. Antimicrob Agents Chemother. 2008;52:4420-4431.